Key result
Phospholamban loss of function increases stress-induced arrhythmia phenotypes by shortening action potential duration.
Why the study?
How genetic predispositions contribute to AF-associated phenotypes remains unknown, largely due to a lack of experimental systems to study gene function on rhythm parameters in human atrial and whole-organ models.
A multi-model experimental platform identified phospholamban loss of function as a central regulator of atrial rhythm homeostasis, providing mechanistic insights into the genetic basis of atrial fibrillation.
Does not support clinical translation of phospholamban targeting in AF; hypothesis-generating from animal data and leaves open human relevance.
Atrial fibrillation (AF) is a common and genetically inheritable form of cardiac arrhythmia; however, it is currently not known how these genetic predispositions contribute to the initiation and/or maintenance of AF-associated phenotypes. One major barrier to progress is the lack of experimental systems to investigate the effects of gene function on rhythm parameters in models with human atrial and whole-organ relevance. Here, we assembled a multi-model platform enabling high-throughput characterization of the effects of gene function on action potential duration and rhythm parameters using human induced pluripotent stem cell-derived atrial-like cardiomyocytes and a Drosophila heart model, and validation of the findings using computational models of human adult atrial myocytes and tissue. As proof of concept, we screened 20 AF-associated genes and identified phospholamban loss of function as a top conserved hit that shortens action potential duration and increases the incidence of arrhythmia phenotypes upon stress. Mechanistically, our study reveals that phospholamban regulates rhythm homeostasis by functionally interacting with L-type Ca2+ channels and NCX. In summary, our study illustrates how a multi-model system approach paves the way for the discovery and molecular delineation of gene regulatory networks controlling atrial rhythm with application to AF.
No takes yet. Share an insight, caveat, or question.
Kervadec et al. (2023) studied Atrial fibrillation. Phospholamban loss of function was evaluated on Action potential duration and incidence of arrhythmia phenotypes upon stress. Screening of 20 AF-associated genes identified phospholamban loss of function as a central regulator that shortens action potential duration and increases arrhythmia phenotypes upon stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: